MAC
33
-11
NOC
35
-9
DHR
44
-2
APD
42
2
VMC
69
-11
EQT
59
2
LLY
56
9
FOXA
53
-11
HUM
34
-2
EA
60
-3
NSC
73
23
CLX
44
-2
PFE
23
-5
RIG
32
3
KSS
28
-5
MMM
64
5
NAVI
46
6
A
47
-4
SE
80
-8
PNC
65
-2
MAC
33
-11
NOC
35
-9
DHR
44
-2
APD
42
2
VMC
69
-11
EQT
59
2
LLY
56
9
FOXA
53
-11
HUM
34
-2
EA
60
-3
NSC
73
23
CLX
44
-2
PFE
23
-5
RIG
32
3
KSS
28
-5
MMM
64
5
NAVI
46
6
A
47
-4
SE
80
-8
PNC
65
-2
Financhill
Back

Franklin Street Properties Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
17

FSP
Franklin Street Properties

Last Price:
$1.51
Seasonality Move:
-1.87%
Sell
42

SRPT
Sarepta Therapeutics

Last Price:
$36.36
Seasonality Move:
13.8%
Sell
17
Franklin Street Properties (FSP) is a Sell

Is Franklin Street Properties a Buy, Sell or Hold?

  • The current Franklin Street Properties [FSP] share price is $1.52. The Score for FSP is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • FSP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
42
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $36.27. The Score for SRPT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FSP Stock Price Chart

What is Franklin Street Properties's stock price today?

  • The Franklin Street Properties share price today is $1.52
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FSP is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $36.27
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

FSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 43.14 Sell
Chaikin Money Flow: -32032 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.49 - 1.59) Sell
Bollinger Bands (100): (1.63 - 1.93) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -7.02 Sell
Relative Strength Index (14 RSI): 22.68 Sell
Chaikin Money Flow: -5425494 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.24 - 62.32) Sell
Bollinger Bands (100): (65.54 - 121.78) Sell

FSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.53 Sell
20-day SMA: 1.53 Sell
50-day SMA: 1.68 Sell
200-day SMA: 1.76 Sell
8-day EMA: 1.52 Sell
20-day EMA: 1.55 Sell
50-day EMA: 1.65 Sell
200-day EMA: 1.78 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 51.08 Sell
20-day SMA: 54.75 Sell
50-day SMA: 69.96 Sell
200-day SMA: 111.27 Sell
8-day EMA: 46.82 Sell
20-day EMA: 54.19 Sell
50-day EMA: 68.41 Sell
200-day EMA: 100.79 Sell

Franklin Street Properties Earnings Growth & FSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.81 per share, an increase next quarter of $0.87 per share, a decrease this year of $3.97 per share, and an increase next year of $8.43 per share.

Franklin Street Properties Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):